Calcium dysregulation has emerged as a central pathological mechanism in Alzheimer's disease (AD), representing a convergence point for amyloid-beta (Aβ) toxicity, tau pathology, and neuronal death. First proposed by Khachaturian in 1989, the calcium hypothesis of AD posits that aging-related disruptions in calcium homeostasis initiate and amplify the neurodegenerative process[1]. This comprehensive review examines the molecular mechanisms of calcium dysregulation in AD, from membrane channel alterations to intracellular store dysfunction, and their implications for therapeutic development.
The calcium hypothesis integrates multiple pathogenic mechanisms including the amyloid hypothesis, tau pathology, neuroinflammation, and mitochondrial dysfunction into a unified framework. Critically, calcium dysregulation occurs early in disease progression—often before detectable amyloid plaque deposition—particularly in carriers of presenilin (PSEN1/PSEN2) mutations that cause familial AD.
Neurons maintain cytosolic free calcium at approximately 50–100 nM—10,000-fold lower than extracellular concentrations (~2 mM). This steep gradient enables calcium to serve as a versatile second messenger when channels open to allow influx.
Calcium entry channels:
Intracellular calcium stores:
Calcium extrusion and buffering:
Calcium signals are decoded by effector proteins:
Aβ disrupts calcium homeostasis through multiple mechanisms[2]:
Calcium-permeable membrane pores: Aβ oligomers insert into neuronal membranes and form ion channel-like pores that allow unregulated calcium influx. These "amyloid pores" are composed of 4–6 Aβ peptides arranged in an annular structure[3]
NMDA receptor potentiation: Aβ oligomers enhance NMDA receptor activity, leading to excitotoxicity. Aβ promotes extrasynaptic NMDA receptor activation, which triggers pro-death signaling pathways rather than the pro-survival pathways activated by synaptic NMDA receptors
L-type VGCC upregulation: Aβ increases L-type calcium channel expression and function, contributing to sustained calcium elevation
ER calcium release: Aβ increases IP3R-mediated and RyR-mediated calcium release from the ER, amplifying calcium signals. Aβ also impairs SERCA pump function, reducing ER calcium refilling capacity
Mitochondrial calcium overload: Aβ accumulates in mitochondria and impairs MCU function, leading to mitochondrial calcium overload, permeability transition pore opening, and apoptosis[4]
Presenilin mutations provide the strongest genetic evidence for the calcium hypothesis. Over 300 PSEN1 and PSEN2 mutations cause familial AD, and the majority dysregulate ER calcium signaling through multiple mechanisms[5]:
Loss of ER calcium leak function: Wild-type presenilins form ER calcium leak channels independent of their gamma-secretase activity. FAD mutations reduce this leak, causing ER calcium overloading and exaggerated IP3R/RyR-mediated release
Enhanced IP3R-mediated release: PSEN1 mutations increase IP3R channel open probability, producing exaggerated calcium release in response to physiological stimuli
Altered ryanodine receptor function: FAD presenilin mutations upregulate RyR expression (particularly RyR2 and RyR3) and increase RyR-mediated calcium release
Impaired SOCE: Presenilin mutations reduce store-operated calcium entry, potentially impairing synaptic calcium signals required for normal LTP
ER-mitochondria calcium transfer: Presenilins localize to mitochondria-associated ER membranes (MAMs), and FAD mutations increase ER-mitochondria calcium transfer through the IP3R-VDAC-MCU axis, promoting mitochondrial dysfunction
Tau protein both results from and contributes to calcium dysregulation:
APOE4 genotype—the strongest genetic risk factor for sporadic AD—influences calcium homeostasis:
Calcium dysregulation directly impairs synaptic function:
Calpain overactivation is a major consequence of calcium overload:
Mitochondrial calcium buffering capacity is exceeded in AD, leading to:
Calcium dysregulation activates neuroinflammatory pathways:
SOCE represents a critical mechanism for replenishing intracellular calcium stores[6]:
The ER is a major calcium storage organelle containing approximately 10-100 times more calcium than the cytosol[7]:
ER calcium homeostasis:
Aβ effects on ER calcium:
Unfolded protein response (UPR): ER stress activates the UPR, which initially attempts to restore homeostasis but can trigger apoptosis if stress persists.
Calcium dysregulation represents a convergent pathological mechanism in AD that bridges amyloid pathology, tau pathology, synaptic dysfunction, and neuronal death. The calcium hypothesis provides a unifying framework for understanding AD pathogenesis and identifies multiple therapeutic targets:
While current treatments addressing calcium dysregulation provide modest benefit, ongoing research into specific calcium-modulating therapies offers hope for more effective interventions.
Khachaturian ZS. The role of calcium ions in the pathogenesis of Alzheimer's disease. Arch Neurol. 1989. ↩︎
LaFerla FM. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci. 2002. ↩︎
Arispe N, Rojas E, Pollard HB. Alzheimer disease beta-amyloid proteins form calcium-permeable channels in artificial membranes and in neurons. Proc Natl Acad Sci USA. 1993. ↩︎
Caldwell CC, Yao J, Brinton RD. Targeting mitochondrial dysfunction for Alzheimer's disease prevention. Neurotherapeutics. 2019. ↩︎
Tu H, Nelson O, Bezprozvanny A, et al. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell. 2006. ↩︎
Sheng R, Liu G, Wang L, et al. Store-operated calcium entry in Alzheimer's disease: progress and therapeutic implications. Mol Neurobiol. 2022. ↩︎
Popugaeva E, Pchitskaya E, Bezprozvanny I. Endoplasmic reticulum calcium dysregulation in Alzheimer's disease. J Alzheimers Dis. 2017. ↩︎